Insider · CIK 0001478916

Schmid John P.

Reports to the SEC for 13 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001478916

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	BLSMBlossomHill Therapeutics, Inc.P Purchase	Director	PPurchase	+6,000 sh	$16.00	+$96K	6,000
2026-06-15	ANABANAPTYSBIO, INCM Exercise/Conversion	Director	MExercise/Conversion	+6,030 sh	—	—	37,652
2026-06-15	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,030 sh	—	—	0
2026-06-15	TRAXFirst Tracks Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,030 sh	—	—	37,652
2026-06-15	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,030 sh	—	—	0
2026-06-09	DSGNDesign Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2026-05-12	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+15K sh	—	—	15,000
2026-05-12	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+42K sh	—	—	42,000
2026-05-12	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+2,500 sh	—	—	2,500
2026-05-12	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,200 sh	—	—	9,200
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.6K sh	—	—	10,600
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,510
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,510
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+6,030 sh	—	—	6,030
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+4,000 sh	—	—	4,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	15,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	6,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	6,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	11,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	11,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,200 sh	—	—	9,200
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+9,200 sh	—	—	9,200
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.6K sh	—	—	10,600
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+10.6K sh	—	—	10,600
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.5K sh	—	—	16,510
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,510
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.5K sh	—	—	16,510
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,510
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	5,500
2026-04-20	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2026-03-30	ANABANAPTYSBIO, INCS Sale	Director	SSale	−12.6K sh	$55.71	−$702K	39,671
2026-03-30	ANABANAPTYSBIO, INCS Sale	Director	SSale	−7,527 sh	$56.70	−$427K	32,144
2026-03-30	ANABANAPTYSBIO, INCS Sale	Director	SSale	−522 sh	$57.40	−$30K	31,622
2026-01-06	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2026-01-06	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	Director	AAward	+4,000 sh	—	—	4,000
2025-12-23	ANABANAPTYSBIO, INCJ Other	Director	JOther	−11.1K sh	$51.00	−$564K	0
2025-08-11	BBOTBridgeBio Oncology Therapeutics, Inc.M Exercise/Conversion	Former Director	MExercise/Conversion	+30K sh	—	—	30,000
2025-08-11	BBOTBridgeBio Oncology Therapeutics, Inc. · Class B ordinary sharesM Exercise/Conversion	Former Director	MExercise/Conversion	−30K sh	—	—	0

Recent filings

Accepted (ET)
Aug 104
Schmid John P.0001478916-26-000015
SEC(opens sec.gov)
Jun 174
Schmid John P.0001478916-26-000011
SEC(opens sec.gov)
Jun 174
Schmid John P.0001478916-26-000012
SEC(opens sec.gov)
Jun 124/A
Schmid John P.0001478916-26-000010
SEC(opens sec.gov)
Jun 114
Schmid John P.0001478916-26-000009
SEC(opens sec.gov)
May 144
Schmid John P.0001478916-26-000007
SEC(opens sec.gov)
Apr 224
Schmid John P.0001478916-26-000005
SEC(opens sec.gov)
Apr 224
Schmid John P.0001478916-26-000006
SEC(opens sec.gov)

Companies

Address

C/O BLOSSOMHILL THERAPEUTICS, INC. 10255 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121